About PER - Careers

Physicians' Education Resource (PER) is medical publishing and education company specializing in Oncology. As a subsidiary of MMH Partners L.P., we are associated with several other subsidiaries dedicated to providing improved treatment and care to cancer patients through educational programs.

Company Background

PER is dedicated to coordinating and implementing superior educational opportunities that enable physicians and health care professionals to remain current and responsive to advances in medical care. PER's ultimate goal is to accelerate the transfer of the rapidly evolving findings in oncology to the practicing physician in order to sustain high quality, cost-effective patient care. PER may present locally, regionally, nationally or internationally as deemed appropriate. We provide a variety of instructional formats, including CME accredited conferences, protocol meetings, and educational publications, audio, video and other enduring materials.

PER was founded in 1996 and has expanded significantly in products and services ever since. We currently have over 135 employees and have experienced continual growth since our inception. We are located in the Uptown area of Dallas, TX.

Company Benefits

We offer a competitive compensation and benefits package consisting of the following:

Medical - choice of 3 insurance plans

Dental Insurance

Vision Insurance

Matching 401K

100% subsidized Short & Long Term Disability

100% subsidized Life Insurance

Free enrollment in company Wellness Program

Onsite fitness center

Onsite yoga classes

Free parking

Access to Katy Trail and Turtle Creek Trails

Questions about PER Careers?

For more infomation about careers and benefits at Physicians' Education Resource, please email Jennifer Cunnings at jennifer.cunnings@mmhlp.com.

Online CME Updates

NSCLC TODAY

New Developments in Adjuvant Therapy for Patients With Early-Stage NSCLC

Get updates on new developments in adjuvant therapy for patients with early-stage NSCLC. This program also includes a Q&A with our expert with selected questions from participants. Take part in this OncoLogue today.

Go to OncoLogue >>

PROSTATE ADVANCES

E-Lert: Emerging Therapies for Advanced Prostate Cancer

Obtain information on emerging therapies and ongoing clinical trials for the treatment of patients with advanced CRPC. Learn to evaluate the safety and efficacy of new therapies and appraise novel bone-targeted therapies.

Tune in Now >>

ONCOLOGY CONSULTATION

Treatment of a 54-Year-Old Patient With Locally Advanced Non–Small-Cell Lung Cancer

Find out new combined modality regimens and the role of PCI in locally advanced NSCLC. Phase II trials of new regimens in locally advanced NSCLC demonstrated feasibility and efficacy, leading to phase III trials.

Read in Full >>